{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T07:56:26Z","timestamp":1784447786347,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["2014R1A5A2009242"],"award-info":[{"award-number":["2014R1A5A2009242"]}]},{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["2022R1F1A1072458"],"award-info":[{"award-number":["2022R1F1A1072458"]}]},{"name":"Bio &Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science &ICT","award":["2017M3A9G8083382"],"award-info":[{"award-number":["2017M3A9G8083382"]}]},{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea","award":["HR22C1832"],"award-info":[{"award-number":["HR22C1832"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1245\/s10434-023-13191-2","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T19:02:36Z","timestamp":1677265356000},"page":"4669-4677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study"],"prefix":"10.1245","volume":"30","author":[{"given":"Jeeyeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeongju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejung","family":"Keum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Soo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Jee-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Du","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"issue":"1","key":"13191_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2014an update. Cancer Epidemiol Biomark Prev. 2016;25(1):16\u201327.","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"4","key":"13191_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","volume":"26","author":"LA Torre","year":"2017","unstructured":"Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomark Prev. 2017;26(4):444\u201357.","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"5","key":"13191_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/CEJ.0000000000000594","volume":"29","author":"C Santucci","year":"2020","unstructured":"Santucci C, Carioli G, Bertuccio P, et al. Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev. 2020;29(5):367\u201381.","journal-title":"Eur J Cancer Prev."},{"issue":"3","key":"13191_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","volume":"5","author":"O Yersal","year":"2014","unstructured":"Yersal O, Barutca S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412\u201324.","journal-title":"World J Clin Oncol."},{"issue":"2","key":"13191_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2231-4040.72251","volume":"1","author":"GN Sharma","year":"2010","unstructured":"Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK. Various types and management of breast cancer: an overview. J Adv Pharm Technol Res. 2010;1(2):109\u201326.","journal-title":"J Adv Pharm Technol Res."},{"issue":"1","key":"13191_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.annonc.2019.10.012","volume":"31","author":"J Heil","year":"2020","unstructured":"Heil J, Kuerer HM, Pfob A, et al. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol. 2020;31(1):61\u201371.","journal-title":"Ann Oncol."},{"issue":"12","key":"13191_CR7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/bjs\/znac305","volume":"109","author":"D Cocco","year":"2022","unstructured":"Cocco D, Shah C, Wei W, Wilkerson A, Grobmyer SR, Al-Hilli Z. Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis. Br J Surg. 2022;109(12):1293\u20139.","journal-title":"Br J Surg."},{"issue":"19","key":"13191_CR8","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836\u201346.","journal-title":"N Engl J Med."},{"issue":"9869","key":"13191_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805\u201316.","journal-title":"Lancet."},{"issue":"2","key":"13191_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1200\/JCO.2016.67.4887","volume":"35","author":"EA Perez","year":"2017","unstructured":"Perez EA, Barrios C, Eiermann W, et al. Trastuzumab emtansine with or without pertuzumab versus trastuzumab plus taxane for human epidermal growth factor receptor 2-positive, advanced breast cancer: primary results from the phase III MARIANNE Study. J Clin Oncol. 2017;35(2):141\u20138.","journal-title":"J Clin Oncol."},{"issue":"10","key":"13191_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S1470-2045(14)70320-1","volume":"15","author":"E de Azambuja","year":"2014","unstructured":"de Azambuja E, Holmes AP, Piccart-Gebhart M, et al. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response. Lancet Oncol. 2014;15(10):1137\u201346.","journal-title":"Lancet Oncol."},{"issue":"3","key":"13191_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","volume":"222","author":"AE Giuliano","year":"1995","unstructured":"Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222(3):394\u20139.","journal-title":"Ann Surg."},{"issue":"2","key":"13191_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0748-7983(98)91303-8","volume":"24","author":"U Veronesi","year":"1998","unstructured":"Veronesi U, Zurrida S, Galimberti V. Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies. Eur J Surg Oncol. 1998;24(2):93\u20135.","journal-title":"Eur J Surg Oncol."},{"issue":"7","key":"13191_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/jso.25010","volume":"117","author":"DB Percy","year":"2018","unstructured":"Percy DB, Pao JS, McKevitt E, Dingee C, Kuusk U, Warburton R. Number of nodes in sentinel lymph node biopsy for breast cancer: are surgeons still biased? J Surg Oncol. 2018;117(7):1487\u201392.","journal-title":"J Surg Oncol."},{"issue":"6","key":"13191_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA."},{"issue":"10","key":"13191_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326.","journal-title":"JAMA."},{"issue":"12","key":"13191_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol."},{"issue":"9","key":"13191_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jcp.52.9.681","volume":"52","author":"G Cserni","year":"1999","unstructured":"Cserni G. The reliability of sampling three to six nodes for staging breast cancer. J Clin Pathol. 1999;52(9):681\u20133.","journal-title":"J Clin Pathol."},{"issue":"2","key":"13191_CR19","first-page":"693","volume":"31","author":"F Lumachi","year":"2011","unstructured":"Lumachi F, Norberto L, Zanella S, et al. Axillary node sampling in conjunction with sentinel node biopsy in patients with breast cancer a prospective preliminary study. Anticancer Res. 2011;31(2):693\u20137.","journal-title":"Anticancer Res."},{"issue":"6","key":"13191_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12262-015-1300-1","volume":"77","author":"KJ Edwards","year":"2015","unstructured":"Edwards KJ, Dordea MA, French R, Kurup V. Role of combined sentinel lymph node biopsy and axillary node sampling in clinically node-negative breast cancer. Indian J Surg. 2015;77(6):495\u2013501.","journal-title":"Indian J Surg."},{"key":"13191_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12893-015-0067-4","volume":"15","author":"J Li","year":"2015","unstructured":"Li J, Jia S, Zhang W, et al. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. BMC Surg. 2015;15:79.","journal-title":"BMC Surg."},{"key":"13191_CR22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1200\/GO.20.00246","volume":"6","author":"V Parmar","year":"2020","unstructured":"Parmar V, Nair NS, Vanmali V, et al. Sentinel node biopsy versus low axillary sampling in predicting nodal status of Postchemotherapy Axilla in women with breast cancer. JCO Glob Oncol. 2020;6:1546\u201353.","journal-title":"JCO Glob Oncol."},{"issue":"1","key":"13191_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/bjs.9952","volume":"103","author":"AU Bing","year":"2016","unstructured":"Bing AU, Kerr GR, Jack W, et al. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer. Br J Surg. 2016;103(1):81\u20137.","journal-title":"Br J Surg."},{"issue":"6","key":"13191_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.asjsur.2018.10.004","volume":"42","author":"J Lee","year":"2019","unstructured":"Lee J, Jung JH, Kim WW, et al. 5-year oncological outcomes of targeted axillary sampling in pT1-2N1 breast cancer. Asian J Surg. 2019;42(6):681\u20137.","journal-title":"Asian J Surg."},{"issue":"6","key":"13191_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.5535\/arm.2015.39.6.931","volume":"39","author":"JN Yoo","year":"2015","unstructured":"Yoo JN, Cheong YS, Min YS, Lee SW, Park HY, Jung TD. Validity of quantitative lymphoscintigraphy as a lymphedema assessment tool for patients with breast cancer. Ann Rehabil Med. 2015;39(6):931\u201340.","journal-title":"Ann Rehabil Med."},{"issue":"4","key":"13191_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4048\/jbc.2012.15.4.449","volume":"15","author":"SH Lee","year":"2012","unstructured":"Lee SH, Min YS, Park HY, Jung TD. Health-related quality of life in breast cancer patients with lymphedema who survived more than one year after surgery. J Breast Cancer. 2012;15(4):449\u201353.","journal-title":"J Breast Cancer."},{"issue":"11","key":"13191_CR27","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1001\/jamaoncol.2016.1897","volume":"2","author":"LM Spring","year":"2016","unstructured":"Spring LM, Gupta A, Reynolds KL, et al. Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis. JAMA Oncol. 2016;2(11):1477\u201386.","journal-title":"JAMA Oncol."},{"issue":"10","key":"13191_CR28","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.ejso.2015.07.013","volume":"41","author":"C Criscitiello","year":"2015","unstructured":"Criscitiello C, Giuliano M, Curigliano G, et al. Surgery of the primary tumor in de novo metastatic breast cancer: to do or not to do? Eur J Surg Oncol. 2015;41(10):1288\u201392.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"13191_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.breast.2014.06.004","volume":"23","author":"M Untch","year":"2014","unstructured":"Untch M, Konecny GE, Paepke S, von Minckwitz G. Current and future role of neoadjuvant therapy for breast cancer. Breast. 2014;23(5):526\u201337.","journal-title":"Breast."},{"issue":"6","key":"13191_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500\u201315.","journal-title":"Lancet Oncol."},{"issue":"1","key":"13191_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12282-020-01120-0","volume":"28","author":"M Noguchi","year":"2021","unstructured":"Noguchi M, Inokuchi M, Noguchi M, Morioka E, Ohno Y, Kurita T. Axillary surgery for breast cancer: past, present, and future. Breast Cancer. 2021;28(1):9\u201315.","journal-title":"Breast Cancer."},{"key":"13191_CR32","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1097\/SAP.0000000000001864","volume":"82","author":"AR Johnson","year":"2019","unstructured":"Johnson AR, Kimball S, Epstein S, et al. Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach. Ann Plast Surg. 2019;82:S234\u201341.","journal-title":"Ann Plast Surg."},{"issue":"11","key":"13191_CR33","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1016\/j.ultrasmedbio.2017.07.011","volume":"43","author":"WH Kim","year":"2017","unstructured":"Kim WH, Kim HJ, Jung JH, et al. Ultrasound-guided fine-needle aspiration of non-palpable and suspicious axillary lymph nodes with subsequent removal after tattooing: false-negative results and concordance with sentinel lymph nodes. Ultrasound Med Biol. 2017;43(11):2576\u201381.","journal-title":"Ultrasound Med Biol."},{"issue":"2","key":"13191_CR34","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1245\/s10434-017-6250-3","volume":"25","author":"WH Kim","year":"2018","unstructured":"Kim WH, Kim HJ, Jung JH, et al. Ultrasound-guided restaging and localization of axillary lymph nodes after neoadjuvant chemotherapy for guidance of axillary surgery in breast cancer patients: experience with activated charcoal. Ann Surg Oncol. 2018;25(2):494\u2013500.","journal-title":"Ann Surg Oncol."},{"issue":"29","key":"13191_CR35","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1200\/JCO.20.00459","volume":"38","author":"GE Naoum","year":"2020","unstructured":"Naoum GE, Roberts S, Brunelle CL, et al. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol. 2020;38(29):3430\u20138.","journal-title":"J Clin Oncol."},{"issue":"32","key":"13191_CR36","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213\u20139.","journal-title":"J Clin Oncol."},{"issue":"2","key":"13191_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-016-3821-0","volume":"157","author":"F Sun","year":"2016","unstructured":"Sun F, Skolny MN, Swaroop MN, et al. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat. 2016;157(2):229\u201340.","journal-title":"Breast Cancer Res Treat."},{"key":"13191_CR38","volume-title":"Cancer rehabilitation and survivorship: transdisciplinary approaches to personalized care","author":"JM Armer","year":"2011","unstructured":"Armer JM, Stewart BR, Smith K, Cormier JN. Lymphedema following cancer treatment. In: JL Lester, P Schmitt, editors. Cancer rehabilitation and survivorship: transdisciplinary approaches to personalized care. Pittsburgh, PA: Oncology Nursing Society; 2011."},{"issue":"4","key":"13191_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/lrb.2005.3.208","volume":"3","author":"JM Armer","year":"2005","unstructured":"Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3(4):208\u201317.","journal-title":"Lymphat Res Biol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13191-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:00:29Z","timestamp":1728964829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13191-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["13191"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13191-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jeeyeon Lee, Jin Hyang Jung, Wan Wook Kim, Byeongju Kang, Heejung Keum, Yee Soo Chae, Soo Jung Lee, Ji-Young Park, Nora Jee-Young Park, Tae-Du Jung, and Ho Yong Park declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This study was approved by the Institutional Review Board Committee of the Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea (KNUCH 2015-05-205). In addition, specific inclusion and exclusion criteria were defined according to the approved institutional review board protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the participants involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}